Detalhe da pesquisa
1.
Prolonged delivery of HIV-1 vaccine nanoparticles from hydrogels.
Int J Pharm
; 657: 124131, 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643811
2.
A shift of paradigm: From avoiding nanoparticular complement activation in the field of nanomedicines to its exploitation in the context of vaccine development.
Eur J Pharm Biopharm
; 193: 119-128, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37838145
3.
Immunogenicity of a silica nanoparticle-based SARS-CoV-2 vaccine in mice.
Eur J Pharm Biopharm
; 192: 41-55, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774890
4.
Multivalent display of engineered HIV-1 envelope trimers on silica nanoparticles for targeting and in vitro activation of germline VRC01 B cells.
Eur J Pharm Biopharm
; 181: 88-101, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36272655